Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MEG.0b013e328333df0fPMID 20010298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra.

  2007cited by this paper
• Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors

  2007cited by this paper
• Hyperammonaemia alters the mechanisms by which metabotropic glutamate receptors in nucleus accumbens modulate motor function

  2007cited by this paper
• Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts

  2007cited by this paper
• Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment

  2006cited by this paper
• Minimal hepatic encephalopathy impairs fitness to drive

  2004cited by this paper
• Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.

  2003cited by this paper
• Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis

  2003cited by this paper
• Clinical significance of extrapyramidal signs in patients with cirrhosis.

  2003cited by this paper
• Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.

  2002cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation

  2002cited by this paper
• Cortical origin of mini-asterixis in hepatic encephalopathy

  2002cited by this paper
• Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

  2001cited by this paper
• The prognostic significance of subclinical hepatic encephalopathy

  2000cited by this paper
• Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis.

  2000cited by this paper
• Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

  1999cited by this paper
• Prognostic significance of hepatic encephalopathy in patients with cirrhosis.

  1999cited by this paper
• Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

  1999cited by this paper
• Subclinical hepatic encephalopathy impairs daily functioning

  1998cited by this paper
• MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.

  1997cited by this paper
• Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms

  1996cited by this paper
• Blood Manganese Correlates with Brain Magnetic Resonance Imaging Changes in Patients with Liver Disease

  1996cited by this paper
• [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results].

  1995cited by this paper
• Manganese and chronic hepatic encephalopathy.

  1995cited by this paper
• Gender- and Age-Specific Changes in Motor Speed and Eye-Hand Coordination in Adults: Normative Values for the Finger Tapping and Grooved Pegboard Tests

  1993cited by this paper
• Reliability of the columbia scale for assessing signs of parkinson's disease

  1993cited by this paper
• Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy

  1977cited by this paper
• The Stroop Test: Selective Attention to Colours and Words

  1969cited by this paper
• THE ACQUIRED (NON-WILSONIAN) TYPE OF CHRONIC HEPATOCEREBRAL DEGENERATION

  1965cited by this paper

• New-onset extrapyramidal symptoms in hepatic cirrhosis without neuroimaging signs of encephalopathy.

  2019cites this paper
• A discussion of new-onset extrapyramidal syndrome without tremor and neuroimaging signs of encephalopathy following hepatic cirrhosis

  2019cites this paper
• Systematic review: patient‐reported outcomes in chronic hepatitis C ‐ the impact of liver disease and new treatment regimens

  2015cites this paper
• Quality of Life Issues for Patients with Cirrhosis

  2015cites this paper
• Loss of tyrosine hydroxylase expression within the nigro-striato-cortical pathways in the cirrhotic rat: the possible restorative effect of the neurosteroid dehydroepiandrosterone sulfate.

  2013cites this paper
• The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy

  2013cites this paper
• Quality of Life in Hepatic Encephalopathy

  2012cites this paper
• Diagnosis of Minimal Hepatic Encephalopathy

  2012cites this paper
• Randomised clinical trial: rifaximin improves health‐related quality of life in cirrhotic patients with hepatic encephalopathy – a double‐blind placebo‐controlled study

  2011cites this paper